Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Brachytherapy. 2013 Mar 1;12(3):210–216. doi: 10.1016/j.brachy.2012.10.006

Fig. 1.

Fig. 1

Mean scores on the Expanded Prostate cancer Index Composite (EPIC) survey for urinary morbidity at baseline, 1 month, 4 months, 8 months, and 12 months after an 125I implant for prostate brachytherapy. (A) urinary function, (B) urinary irritative/obstructive symptoms, (C) urinary bother, (D) urinary incontinence. Bars show 95% confidence intervals (CIs).